The global medical devices market was valued at USD 745.25 billion in 2025 and is projected to reach USD 797.19 billion in 2026. It is expected to grow to approximately USD 1.36 trillion by 2034, representing a compound annual growth rate of 6.97% from 2026 to 2034[1].
This expansion places higher demands on raw materials, core components, manufacturing capabilities, and vendor networks. As a dedicated exhibition for the medical device supply chain, Medtec China provides direct access to qualified industry partners. Applications for free admission to Medtec China 2026 are now in full swing.
Global De-Risking Is Making Medical Device Supply Chains More Complex
The global medical device landscape is undergoing structural adjustments driven by trade policy shifts and regulatory changes. Healthcare manufacturers face mounting pressure to mitigate concentration risks, diversify vendor bases, and establish regional supply networks. Industry data shows that localized procurement guidelines and stricter compliance frameworks are prompting companies to systematically re-evaluate their current vendor partnerships.
To maintain operational continuity, procurement teams are actively de-risking their supply architectures. Dual-sourcing models and regional supplier integration have transitioned from cost-optimization options to essential risk-management tactics.
For companies that are reassessing their supplier and manufacturing networks, Medtec China 2026 can serve as a valuable exhibition for efficiently exploring new supply resources and partnership opportunities.
Medtec China facilitates direct engagement with international and domestic vendors capable of meeting strict regulatory and technical requirements.
Explore how Medtec China supports innovation across the medical device supply chain: Medtec China 2026: Innovating the Medical Device Supply Chain
What Challenges and Risks Are Medical Device Supply Chain Players Facing?
Medical device manufacturers encounter persistent operational hurdles that can disrupt production timelines and market launch schedules. Navigating these headwinds requires evaluating specific vulnerability areas.
Key Industry Challenges:
◇ Bottleneck risks in raw materials and core components: Reliance on single-source suppliers for specialized polymers, biocompatible metals, and micro-components leaves production exposed to disruption.
◇ Geopolitical and trade developments: Evolving international trade rules and tariff structures complicate long-term medical device sourcing planning and inflate total cost of ownership.
◇ Insufficient supply chain resilience: Many organizations lack qualified secondary suppliers or rapid emergency response protocols when primary vendors encounter shortages.
◇ Growing pressure around compliance and traceability: Regulatory updates mandate detailed material origin documentation, ISO 13485 adherence, and complete component traceability.
◇ Survival pressure amid industry consolidation: Ongoing market consolidation places intense pressure on non-leading OEMs and medical device suppliers, forcing buyers to assess vendor financial stability.
Whether companies are dealing with the lack of a second-source supplier, sourcing critical components, regional supply chain planning, or insufficient manufacturing capacity, the underlying need is essentially the same: to expand the pool of supply chain options that they can access and evaluate. Medtec China addresses these operational gaps by gathering verified medical device suppliers into a single, structured environment.
In addition to physical exhibits, Medtec China features technical forums and closed-door seminars. These educational sessions address regulatory policy shifts, quality management frameworks, material innovations, and medical device contract manufacturing developments, providing engineering and procurement teams with practical guidance.
How Can Medtec China 2026 Help Companies Build More Resilient Medical Device Supply Chains?
Medtec China 2026 will take place from September 1 to 3, 2026, at the Shanghai New International Expo Centre, Halls N1 to N4. The 20th edition is planned at 47,000 square meters, with 1,100 exhibitors and an estimated 93,000 visitors.
| Sourcing Challenge | Medtec China On-Site Solution |
| Single-source vulnerability | Compare alternatives across 1,100 exhibitors covering materials, components, manufacturing services, equipment, testing, packaging, and related services |
| Critical materials or components | Review medical materials, core components, precision processing, tubing, adhesives, and other upstream resources |
| Contract manufacturing capacity | Evaluate OEM/ODM and medical device contract manufacturing partners through direct technical discussions |
| Regional sourcing diversification | Assess suppliers from China and other participating markets |
| Compliance and quality requirements | Meet testing, metrology, inspection, consulting, packaging, sterilization, and cleanroom solution providers |
The exhibition layout supports structured medical device sourcing. Hall N1 and Hall N2 focus on medical materials, core components, and related processing technologies. Hall N3 covers full-service OEM/ODM contract manufacturing, medical integration and automation, drive control and robotics, and smart-factory solutions. Hall N4 features medical packaging, sterilization, labeling, and cleanroom technologies; medical device R&D and design services, engineering software, and regulatory consulting and compliance services; as well as testing equipment and systems, precision metrology instruments, inspection technologies, and quality-assurance supplies.
For sourcing teams, this structure provides several practical benefits:
▪ Gain access to a larger supplier pool. More medical device suppliers allow teams to compare technical fit, quality systems, capacity, lead times, and commercial conditions.
▪ Review more of the medical device supply chain in one location. Visitors can move from materials and components to manufacturing, testing, packaging, and supporting services.
▪ Expand regional sourcing options. Medtec China provides access to Chinese and international suppliers within an exhibition positioned around Asia’s medical device manufacturing and supply ecosystem.
▪ Look beyond components. OEM, ODM, and medical device contract manufacturing partners can be evaluated alongside manufacturing equipment and process providers.
▪ Use face-to-face evaluation. Direct discussions can reveal engineering responsiveness, process knowledge, tooling capability, quality practices, and production constraints that may not be clear from supplier directories.
These interactions do not replace formal supplier qualification. However, they can make early-stage screening more efficient and help companies identify medical device suppliers for deeper technical, commercial, and compliance review.
Conclusion
The core significance of Medtec China 2026 lies in helping medical device companies expand their supply chain optionality. By broadening access to raw materials, precision components, processing technologies, OEM/ODM services, and production partners, organizations can build durable supply chain resilience.
If you are planning supplier diversification, critical component medical device sourcing, regional supply chain deployment, or manufacturing capacity strategies for 2026–2027, you can apply for a free visitor pass to Medtec China 2026 and come to the event with your own supply chain requirements checklist.
The exhibition will take place from September 1–3, 2026, at the Shanghai New International Expo Centre, with free pre-registration available until August 30.
References:
[1] B, D. (2026, August 13). Medical devices market size, share & trends analysis report: By device type, device class, end user, and region, forecasts 2026–2034. Straits Research. https://straitsresearch.com/report/medical-devices-market